Hormone replacement therapy and its potential relationship to dementia

Journal of the American Geriatrics Society

Volumn 44, Issue 7, 1996, Pages 878-880

  Kuller, Lewis H ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

AGED; ALZHEIMER DISEASE; DEMENTIA; ESTROGEN THERAPY; FEMALE; HUMAN; MALE; NOTE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MALE;

EID: 0030186648     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1996.tb03753.x     Document Type: Note

References (34)

1. Birge SJ,. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 1996; 44: 0000-0000.
2. Cummings JL,. Dementia: The failing brain. Lancet 1995; 345: 1481-1484.
3. Murphy M., The molecular pathogenesis of Alzheimer's disease: Clinical prospects. Lancet 1992; 340: 1512-1515.
4. Regland B, Gottfries CG,. The role of amyloid β-protein in Alzheimer's disease. Lancet 1992; 340: 467-469.
5. Yankner BA, Mesulam MM,. β-amyloid and the pathogenesis of Alzheimer's disease. N Engl J Med 1991; 325: 1849-1857.
6. Cooper B., The epidemiology of primary degenerative dementia and related neurological disorders. Eur Arch Psychiatry Clin Neurosci 1991; 240: 223-233.
7. Hebert LE, Scherr PA, Beckett LA, et al,. Age-specific incidence of Alzheimer's disease in a community population. JAMA 1995; 273: 1354-1359.
8. Ganguli M, Ratcliff G, Huff FJ, et al,. Effects of age, gender, and education on cognitive tests in a rural elderly community sample: Norms from the Monongahela Valley Independent Elders Survey (MoVIES). Neuroepidemiology 1991; 10: 42-52.
9. Feskens EJM, Havekes LM, Kalmijn S, et al,. Apolipoprotein E4 allele and cognitive decline in elderly men. Br Med J 1994; 309: 1202-1206.
10. Locke PA, Conneally PM, Tanzi RE, et al,. Apolipoprotein E4 allele and Alzheimer's disease: Examination of allelic association and effect on age at onset in both early- and late-onset cases. Genet Epidemiol 1995; 12: 83-92.
11. Fratiglioni L., Epidemiology of Alzheimer's disease: Issues of etiology and validity. Acta Neurol Scand 1993; 87: 1-912.
12. Snowdon DA, Kemper SJ, Mortimer JA, et al,. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life: Findings from the Nun Study. JAMA 1996; 275: 528-532.
13. Braekhus A, Laake K, Engedal KA,. Low "normal" score on the mini-mental state examination predicts development of dementia after three years. J Am Geriatr Soc 1995; 43: 656-661.
14. Fratiglione L, Jorm AF, Grut M, et al,. Predicting dementia from the mini-mental state examination in an elderly population: The role of education. J Clin Epidemiol 1993; 46: 281-286.
15. Ferrucci L, Guralnik JM, Salive ME, et al,. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 1996; 44: 237-241.
16. White L., Is silent cerebrovascular disease an important cause of late-life cognitive decline? J Am Geriatr Soc 1996; 44: 328-330.
17. Boone KB, Miller BL, Lesser IM, et al,. Cognitive deficits with white-matter lesions in healthy elderly. Arch Neurol 1992; 49: 549-554.
18. Hofman A, Rocca WA, Brayne C, et al,. The prevalence of dementia in Europe: A collaborative study of 1980-1990 findings. Int J Epidemiol 1991; 20: 736-748.
19. Barrett-Connor E, Kritz-Silverstein D., Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269: 2637-2641.
20. Sherwin BB,. Estrogenic effects on memory in women. Ann N Y Acad Sci 1994; 743: 213-231.
21. Simkins JW, Singh M, Bishop J., The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging 1994; 15 (suppl): S195-197.
22. Kuller LH, Meilahn E, Bunker C, et al,. Development of risk factors for cardiovscular disease among women from adolescence to older ages. Am J Med Sci 1995; 310:(suppl): S91-100.
23. Welch HG, Albertsen PC, Nease RF, et al,. Estimating treatment benefits for the elderly: The effect of competing risks. Ann Intern Med 1996; 124: 577-584.
24. Bradbury J., β-amyloid vasoactivity in Alzheimer's disease. Lancet 1996; 347: 750.
25. Kuller L, Borhani N, Furberg C, et al,. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol 1994; 139: 1164-1179.
26. Bryan RN, Manolio TA, Schertz LD, et al,. A method for using MR to evaluate the effects of cardiovascular disease on the brain: The Cardiovascular Health Study. Am J Neuroradiol 1994; 15: 1625-1633.
27. Manolio TA, Kronmal RA, Burke GL, et al,. Magnetic resonance abnormalities and cardiovascular disease in older adults: The Cardiovascular Health Study. Stroke 1994; 25: 318-327.
28. Bots ML, Van Swieten JC, Breteler MMB, et al,. Cerebral white matter lesions and atherosclerosis in the Rotterdam Study. Lancet 1993; 341: 1232-1237.
29. Kawamoto A, Shimada K, Matsubayashi K, et al,. Factors associated with silent multiple lacunar lesions on magnetic resonance imaging in asymptomatic elderly hypertensive patients. Clin Exp Pharmacol Physiol 1991; 18: 605-610.
30. Ganguli M, Belle S, Ratcliff G, et al,. Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: The MoVIES Project. J Gerontol 1993; 48: M152-161.
31. Reiman EM, Caselli RJ, Yun LS, et al,. Preclinical evidence of Alzheimer's disease in persons homozygous for the E4 allele for apolipoprotein E. N Engl J Med 1996; 334: 752-758.
32. Farmer ME, Kittner SJ, Abbott RD, et al,. Longitudinally measured blood pressure, anti-hypertensive medication use and cognitive performance: The Framingham Study. J Clin Epidemiol 1990; 43: 475-480.
33. Meyer JS, Judd BW, Tawaklna T, et al,. Improved cognition after control of risk factors for multi-infarct dementia. JAMA 1986; 256: 2203-2209.
34. Psaty BM, Lee M, Savage JP, et al,. Assessing the use of medications in the elderly: Methods and initial experience in the Cardiovascular Health Study. J Clin Epidemiol 1992; 45: 683-692.From the Graduate School of Public.